BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6271966)

  • 1. A gouty family with increased phosphoribosylpyrophosphate synthetase activity: case reports, familial studies, and kinetic studies of the abnormal enzyme.
    Akaoka I; Fujimori S; Kamatani N; Takeuchi F; Yano E; Nishida Y; Hashimoto A; Horiuchi Y
    J Rheumatol; 1981; 8(4):563-74. PubMed ID: 6271966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
    Becker MA; Losman MJ; Itkin P; Simkin PA
    J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
    Losman MJ; Hecker S; Woo S; Becker MA
    J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
    Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: Characterization of purine metabolism in cultured fibroblasts from a gouty family with feedback-resistant phosphoribosylpyrophosphate synthetase.
    Zoref E; Sperling O; De Vries A
    Isr J Med Sci; 1975 Nov; 11(11):1216. PubMed ID: 173692
    [No Abstract]   [Full Text] [Related]  

  • 7. Human phosphoribosylpyrophosphate synthetase: radioimmunochemical quantitation in erythrocytes and fibroblasts.
    Itkin P; Woo S; Becker MA
    J Lab Clin Med; 1984 Jul; 104(1):96-109. PubMed ID: 6330252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased erythrocyte phosphoribosylpyrophosphate synthetase activity and impaired formation in thalassemia minor: a mechanism for decreased adenine nucleotide content.
    Zerez CR; Lachant NA; Tanaka KR
    J Lab Clin Med; 1989 Jul; 114(1):43-50. PubMed ID: 2544652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased 5-phospho-alpha-D-ribose-1-diphosphate synthetase (ribosephosphate pyrophosphokinase, EC 2.7.6.1) activity in rat hepatomas.
    Baló-Banga JM; Weber G
    Cancer Res; 1984 Nov; 44(11):5004-9. PubMed ID: 6091867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. X-linked pattern of inheritance of gout due to mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Zoref E; de Vries A; Sperling O
    Adv Exp Med Biol; 1977; 76A():287-92. PubMed ID: 193372
    [No Abstract]   [Full Text] [Related]  

  • 11. Human phosphoribosylpyrophosphate synthetase. Comparison of purified normal and mutant enzymes.
    Becker MA; Kostel PJ; Meyer LJ
    J Biol Chem; 1975 Sep; 250(17):6822-30. PubMed ID: 169259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mode of genetic transmission of gouty family with increased phosphoribosylpyrophosphate synthetase activity.
    Takeuchi F; Hanaoka F; Yano E; Yamada M; Horiuchi Y; Akaoka I
    Hum Genet; 1981; 58(3):322-30. PubMed ID: 6276287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
    Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
    Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant human phosphoribosylpyrophosphate synthetase altered in regulatory and catalytic functions.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    J Clin Invest; 1980 Jan; 65(1):109-20. PubMed ID: 6243137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoribosylpyrophosphate synthetase in human erythrocytes: assay and kinetic studies using high-performance liquid chromatography.
    Sakuma R; Nishina T; Yamanaka H; Kamatani N; Nishioka K; Maeda M; Tsuji A
    Clin Chim Acta; 1991 Dec; 203(2-3):143-52. PubMed ID: 1663846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered isoelectric property of a superactive 5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase in a patient with clinical gout.
    Nishida Y; Akaoka I; Horiuchi Y
    Biochem Med; 1981 Dec; 26(3):387-94. PubMed ID: 6277305
    [No Abstract]   [Full Text] [Related]  

  • 18. [The pattern of inheritance of a gouty family with increased phosphoribosyl pyrophosphate synthetase activity accompanied by anti-insulin antibody: case report and research of the pedigree (author's transl)].
    Takeuchi F; Fujimori S; Ogita T; Nishida Y; Hashimoto A; Akaoka I; Horiuchi Y; Yano E
    Nihon Naika Gakkai Zasshi; 1979 Dec; 68(12):162-9. PubMed ID: 231076
    [No Abstract]   [Full Text] [Related]  

  • 19. Phosphoribosylpyrophosphate synthetase overactivity as a cause of uric acid overproduction in a young woman.
    García-Pavía P; Torres RJ; Rivero M; Ahmed M; García-Puig J; Becker MA
    Arthritis Rheum; 2003 Jul; 48(7):2036-41. PubMed ID: 12847698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human erythrocyte phosphoribosylpyrophosphate synthetase. Subunit analysis and states of subunit association.
    Becker MA; Meyer LJ; Huisman WH; Lazar C; Adams WB
    J Biol Chem; 1977 Jun; 252(11):3911-8. PubMed ID: 193849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.